The results indicated that it was not SUV39H2, but SUV39H1 down-regulation in the CREMα promoter region of SLE CD4+ T cells that led to a reduction of H3K9me3 eventually promoted CREMα over expression and SLE progression. The gene discussed is CD4; the disease is systemic lupus erythematosus.